This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

YAG Laser Versus Punch Biopsy for the Treatment of Tattoo Skin Markers

This study has been completed.
Information provided by:
Bispebjerg Hospital Identifier:
First received: January 3, 2006
Last updated: June 2, 2008
Last verified: June 2008
The purpose of the study is to compare patient satisfaction, clinical efficacy and adverse effects of Q-switched YAG laser versus punch biopsies for the treatment of tattoo dots that are applied as skin markers in relation to X-ray treatment of malignant disorders.

Condition Intervention
Tattoo Skin Markers Device: Q-switched YAG laser

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single
Primary Purpose: Treatment

Further study details as provided by Bispebjerg Hospital:

Study Start Date: January 2006
Study Completion Date: December 2007

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All

Inclusion Criteria:

  • 18 years or older,
  • Skin types I-IV,
  • No previous laser treatment for the condition.

Exclusion Criteria:

  • Younger than 18 years,
  • Skin types V-VI,
  • Pregnant or lactating women,
  • Previous laser treatment for the condition,
  • Recent exposure to sun or sun-beds,
  • Treatment with oral retinoids within 3 months,
  • Tendency to produce hypertrophic scars or keloids,
  • Immunosuppressive treatment or disorders
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00271674

Bispebjerg Hospital
Copenhagen, Copenhagen NV, Denmark, 2400
Sponsors and Collaborators
Bispebjerg Hospital
Principal Investigator: Merete Haedersdal, MD, PhD, DrMedSci. Bispebjerg Hospital
  More Information Identifier: NCT00271674     History of Changes
Other Study ID Numbers: KF-01-275533
Study First Received: January 3, 2006
Last Updated: June 2, 2008 processed this record on September 19, 2017